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Objectives: The aim of this study was to investigate the
prevalence of familial abdominal aortic aneurysms (AAA) in
a tertiary medical center and to appreciate common cardio-
vascular risk factors for their association with sporadic and
familial AAA.
Methods: Family histories were ascertained by ques-
tionnaire from 405 AAA patients (total 7955 relatives)
treated between 1990-2009 (91% men; age at surgery
67,58.1 years). Familial AAA was defined as having one
or more first or second degree family members suffering
from AAA. Cardiac risk profile was assessed with the Lee’s
Revised Cardiac Risk Index. Univariable en multivariable
analysis were performed to assess differences in atheroscle-
rotic risk factors between sporadic and familial AAA
patients.
Results: Familial AAA was reported in 106 patients
(26%) and in 87 patients (82%) first-degree relatives were
affected. Using multivariable analysis, familial AAA was
significantly associated with lower age of the patient at
diagnosis (OR 0.94; 95%CI 0.91-0.97), reduced incidence pf hypertension (OR 0.35; 95%CI 0.21-0.58) and de-
reased cardiac risk profile (1 risk factor OR 0.60; 95%CI
.35-1.02; 2 risk factors OR 0.49; 95%CI 0.24-0.99)
ompared to patients with sporadic AAA.
Conclusions: Our data show a high proportion of
amilial AAA. The familial AAA patients were diagnosed at
younger age, had a reduced incidence of hypertension and
ess cardiac risk factors. These findings emphasize the im-
ortance of a genetic component in the pathogenesis of
AA and suggest the need for further screening in familial
AA families.
uthor Disclosures: E. J. Bakker: Nothing to disclose;
. E. Hoeks: Dutch foundation ”Lijf en Leven”, Research
rants; D. Majoor Krakauer: Nothing to disclose; D.
oldermans: Merck, Research GrantsNovartis, Research
rantsMedtronic,Research Grants; N. J. Ravensbergen:
othing to disclose; K. M. van de Luijtgaarden: Nothing
o disclose; H. J. Verhagen: Cook, Consulting fees or
ther remuneration (payment)Medtronic,Consulting fees
r other remuneration (payment) Gore, Consulting fees or
ther remuneration (payment);M. T. Voute: DutchHeart
oundation, Research Grants.
R12.
rends in the Utilization of Endovascular Therapy for
lective and Ruptured Abdominal Aortic Aneurysm
rocedures across Canada: A Cohort Study
rasad Jetty1, Don Husereau2. 1Division of Vascular and
ndovascular Surgery, The Ottawa Hospital and the Uni-
ersity of Ottawa, Ottawa, ON, Canada; 2Canadian Agency
or Drugs and Technologies in Health, Ottawa, ON, Can-
da
Objectives: While randomized trials have shown im-
roved operative mortality with Endovascular Aneurysm
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June Supplement 201198S AbstractsRepair (EVAR) but similar long-term mortality rates, en-
thusiasm for EVAR persists and rates of EVAR use continue
to increase. Currently knowledge of utilization rates of
EVAR in Canada is limited.
Methods: Patients who underwent non-ruptured
(AAA) and ruptured AAA (RAAA) repair, by either open
surgical repair (OSR) or EVAR, in Canada were identified
from hospital discharge abstract data. Trends in rates for
OSR and EVAR were calculated by province and by year,
and standardized per 100000 persons over 65 years of age
(per capita).
Results: Between April 2004 and March 2009, 15960
AAA procedures were performed in Canada, either by OSR
(n12204) or EVAR (n3756). The proportion of all
elective AAA procedures by EVAR increased from 11.5% in
2005 to 35.5% in 2009, the highest current proportion of
EVAR utilization in British Columbia (45.0%) and the
lowest in Manitoba (15.8%). After standardization, the
national rate of total procedures was steady, but the rate of
RAAAs declined over the entire study period. Alberta con-
sistently had the highest per capita rates of EVAR use
(38.9), whereas Prince Edward Island had the lowest (8.4).
Provincial variations in EVAR use did not correlate with
differences in co-morbidities. Compared to Canadian aver-
ages, Atlantic Provinces performed the most AAA proce-
dures per capita (137.5 vs. 93.4), had the highest rate of
RAAAs per capita (29.7 vs. 22.2) and the lowest propor-
tional rates of EVAR use.
Conclusions: Use of EVAR in Canada for AAAs has
increased in the past 5 years, without affecting overall AAA
procedure volumes. Large discrepancies in EVAR use exist
across Canada. The Atlantic Provinces had the highest rates
of RAAAs despite having the highest rates for total AAA
procedures, suggesting a population with higher suscepti-
bility for AAAs. This region may also have the largest
potential for future increased use of EVAR.
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Objectives: Thirty percent of patients undergoing
endovascular aneurysm repair (EVAR) have iliac artery
aneurysms. Aneurysmal involvement at the iliac bifurca- aion potentially undermines long-term durability of the
epair. Treatment and outcome in patients undergoing
VAR with unfavorable iliac anatomy is rarely reported.
Methods: Patients who underwent EVAR with aneu-
ysmal involvement at the iliac bifurcation were identified
n two university teaching hospitals. Bell-bottom technique
iliac limb20mm) (BBT) or hypogastric artery emboliza-
ion and iliac limb extension (ILE) were used. Outcomes of
hese two approaches are compared using Pearson Chi-
quare test.
Results: One-hundred-eighty-nine patients were iden-
ified from 2004 to 2009. Ninety-three percent were male,
verage age was 73 years (range 53-91). Indication for
VAR included asymptomatic abdominal aortic aneurysm
AAA) (n157), symptomatic or ruptured aneurysm
n23), and common iliac artery aneurysm (n9). Aver-
ge AAA diameter was 62mm. A total of 237 unfavorable
liac bifurcations were treated—158 iliacs were treated with
BT, 79 underwent ILE. Hypogastric embolization was
chieved by coiling (n54) or vascular plug (n36). Total
eintervention rates were similar for BBT and ILE (7.2% vs
.8%, p0.1) including 3% of BBT and ILE needing rein-
ervention for type 1b or 3 endoleak. There was no signif-
cant difference in limb patency rates. Median follow-up
as 22 months. Thirty-day mortality was 1.5%.
Conclusions: Careful pre-operative planning enables
atients with unfavorable iliac anatomy to be successfully
reated with BBT or ILE. BBT with preservation of the
ypogastrics is not associated with significantly higher rates
f reintervention on mid-term follow-up, therefore when
easible BBT is desirable.
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Objectives: Treatment of retrograde Stanford type A
ortic dissection (RAAD) with endovascular repair has re-
